Market News Call

Big News Coming From Peregrine Pharmaceuticals (NASDAQ:PPHM), Torchlight Energy Resources Inc(NASDAQ:TRCH)

Peregrine Pharmaceuticals(NASDAQ:PPHM) announces presentation of preclinical study results; latest findings from ongoing collaboration with memorial sloan kettering support potential applications for combining car t and anti-ps in treatment of solid tumors  (0.65) For this study,


Analyst’s Update: Amgen, Inc. (NASDAQ:AMGN), Gogo Inc (NASDAQ:GOGO)

UBS initiates Amgen, Inc.(NASDAQ:AMGN ) with a Neutral and price target of $185. During the next four years Amgen sales growth will face intensifying headwinds to Enbrel and key legacy products. The late-stage pipeline,


Stocks In News: Juno Therapeutics Inc (NASDAQ:JUNO), Broadcom Ltd (NASDAQ:AVGO)

Juno Therapeutics Inc(NASDAQ:JUNO) discontinues development of JCAR015 in r/r adult ALL to focus on defined cell product in this setting   (25.31 +1.27) “We continue to experience encouraging signs of clinical benefit in our trial addressing


Kite Pharma Inc (NASDAQ:KITE) Jumps 50% This Week, What Analysts Are Saying Further?

Kite Pharma target raised to $85 at H.C. Wainwright  (71.67 +14.84) H.C. Wainwright raises their KITE tgt to $85 from $78 attributed to our lower discount rate of 17.5%, given the de-risking associated with positive